Gut Peptide Alterations in Type 2 Diabetes and Obesity: A Narrative Review. [PDF]
Tzeravini E +4 more
europepmc +1 more source
Development of Petrelintide: a Potent, Stable, Long-Acting Human Amylin Analogue. [PDF]
Fischer Munch H +14 more
europepmc +1 more source
Pancreatic hypersecretion of amyloid-forming human amylin dysregulates the neuro-immune axis and B cell development in a model of type-2 diabetes. [PDF]
Winford ED +14 more
europepmc +1 more source
Do no harm: managing nausea and vomiting in GLP-1 based obesity therapies. [PDF]
Alhazmi A, le Roux CW.
europepmc +1 more source
Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept. [PDF]
Briere DA +17 more
europepmc +1 more source
Modifiable Factors Affecting the Postprandial Glycemic Response. [PDF]
Wu Y +18 more
europepmc +1 more source
Neuropeptide TIP39 as a pluripotent brain molecule and its potential functions in postpartum depression. [PDF]
Wang S +7 more
europepmc +1 more source
Incretin-Related Pathology and Serum Exosome Detection in Experimental Alcohol-Related Brain Damage. [PDF]
de la Monte SM, Tong M, Yang Y.
europepmc +1 more source
Central pramlintide administration potently suppresses operant responding for sucrose and locomotor activity in male rats. [PDF]
Kern KA +5 more
europepmc +1 more source

